No black box warning on record for Tukysa

As of the latest FDA labeling reviewed, Tukysa (TUCATINIB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tukysa medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Diarrhea : Severe diarrhea, including dehydration, acute kidney injury, and death, has been reported. Administer antidiarrheal treatment as clinically indicated. Interrupt dose, then dose reduce, or permanently discontinue TUKYSA based on severity. ( 2.2 , 5.1 ) • Hepatotoxicity : Severe hepatotoxicity has been reported on TUKYSA. Monitor ALT, AST and bilirubin prior t

No black box warning on record for Tukysa

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Diarrhea : Severe diarrhea, including dehydration, acute kidney injury, and death, has been reported. Administer antidiarrheal treatment as clinically indicated. Interrupt dose, then dose reduce, or permanently discontinue TUKYSA based on severity. ( 2.2 , 5.1 ) • Hepatotoxicity : Severe hepatotoxicity has been reported on TUKYSA. Monitor ALT, AST and bilirubin prior t

Tukysa Black Box Warning

No black box warning on record for Tukysa

Other warnings & precautions

Tukysa Black Box Warning

No black box warning on record for Tukysa

Other warnings & precautions